(Q43621579)

25 November 2017

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. (English)

1 reference

25 November 2017

0 references

L Patel

1

1 reference

25 November 2017

I Pass

2

1 reference

25 November 2017

P Coxon

3

1 reference

25 November 2017

C P Downes

4

1 reference

25 November 2017

S A Smith

5

1 reference

25 November 2017

C H Macphee

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

11

1 reference

25 November 2017

764-768

1 reference

25 November 2017

10

1 reference

The multiple roles of PTEN in tumor suppression

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Impaired Fas response and autoimmunity in Pten+/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2801%2900225-1

7 January 2021

10.1016/S0960-9822(01)00225-1

Identifiers

DOI

1 reference

25 November 2017

1 reference